The Trump administration policy to limit NIH research funding for indirect costs to 15% would significantly lower funding for major research institutions, causing financial strain and potential disruptions in critical research efforts. This move has been criticized as a betrayal of a longstanding partnership between universities and the government that has fueled American innovation and progress.
Key Points
NIH funding for indirect costs may be limited to 15%
Harvard's NIH indirect rate was 69% last year
The move has been criticized as a betrayal of a partnership that has enabled American innovation and progress
Pros
More money may go directly to research rather than overhead costs
Cons
Significantly lower funding for major research institutions
Financial strain on universities and potential disruptions in critical research efforts